News Articles Tagged: Cancer Drug Enhancement

Gimeracil (103766-25-2): A DPD Inhibitor for Cancer Treatment Research

Learn about Gimeracil (CAS 103766-25-2), its role as a DPD inhibitor in cancer therapy, and sourcing options from a leading Chinese manufacturer and supplier.

Oxfendazole in Oncology: Exploring New Frontiers in Cancer Treatment

Delve into the emerging research on Oxfendazole (CAS 53716-50-0) as a potential anti-cancer agent, focusing on its impact on NSCLC and synergistic effects with chemotherapy.

Synergistic Cancer Treatments: How 2'-Deoxycytidine Enhances Chemotherapy

Explore the synergistic potential of 2'-deoxycytidine with conventional chemotherapy agents, its role in sensitizing cancer cells, and its contribution to improved treatment outcomes.